Envoy Medical Regains Nasdaq Listing Compliance After Financing
TipRanks (Fri, 27-Feb 10:16 AM ET)
Envoy Medical Regains Compliance with Nasdaq Listing Requirement
Newsfile (Tue, 24-Feb 8:01 AM ET)
Newsfile (Mon, 23-Feb 8:01 AM ET)
Newsfile (Thu, 19-Feb 8:01 AM ET)
Newsfile (Tue, 17-Feb 8:00 AM ET)
Envoy Medical Announces Closing of Up to $78.0 Million Upsized Public Offering
Newsfile (Thu, 12-Feb 4:05 PM ET)
Envoy Medical Announces Pricing of Up to $78.0 Million Upsized Public Offering
Newsfile (Wed, 11-Feb 9:25 AM ET)
Small Cap Growth Virtual Investor Conference: Presentations Now Available for On-Demand Viewing
Globe Newswire (Fri, 6-Feb 8:35 AM ET)
Small Cap Growth Virtual Investor Conference Agenda Announced for February 5th
Globe Newswire (Mon, 2-Feb 8:35 AM ET)
Envoy Medical to Present at the Small Cap Growth Virtual Investor Conference February 5
Globe Newswire (Thu, 29-Jan 8:35 AM ET)
Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.
Envoy Medical - Class A trades on the NASDAQ stock market under the symbol COCH.
As of March 3, 2026, COCH stock price climbed to $0.73 with 97,331 million shares trading.
COCH has a beta of 0.12, meaning it tends to be less sensitive to market movements. COCH has a correlation of 0.00 to the broad based SPY ETF.
COCH has a market cap of $56.12 million. This is considered a Micro Cap stock.
Last quarter Envoy Medical - Class A reported $42,000 in Revenue and -$.35 earnings per share. This fell short of revenue expectation by $-30,000 and missed earnings estimates by -$.07.
The top ETF exchange traded funds that COCH belongs to (by Net Assets): VTI, IWC, VXF.
COCH has underperformed the market in the last year with a return of -46.7%, while the SPY ETF gained +15.3%. In the last 3 month period, COCH fell short of the market, returning -9.4%, while SPY returned -0.2%. However, in the most recent 2 weeks COCH has outperformed the stock market by returning +21.7%, while SPY returned -0.5%.
COCH support price is $.64 and resistance is $.76 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that COCH shares will trade within this expected range on the day.
